UnknownPhase 2NCT03955601

A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia:

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Principal Investigator
Tariq Mehmood Satti, FCPS
NIBMT
Intervention
Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''(drug)
Enrollment
30 enrolled
Eligibility
2-60 years · All sexes
Timeline
2018 – 2021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03955601 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia →

← Back to all trials